News – WASHINGTON, DC – As the world continues to fight COVID-19, the Front Line COVID-19 Critical Care Alliance (FLCCC) convenes a panel of leading scientific and medical experts from around the world to report The latest research demonstrates the safe and effective use of ivermectin in the prevention and treatment of COVID-19.
Scientists and doctors from the US, UK, EU, South America and Israel will discuss the latest scientific and clinical research and urge governments to adopt Ivermectin use immediately to prevent and treat COVID-19. The discussions will include the latest data on how ivermectin has reduced advanced COVID-19 cases in cities worldwide, the role of ivermectin in early treatment of COVID-19, and why ivermectin needs to be taken immediately as a safe and effective prevention and treatment. of COVID-19.
The panel discussion will take place at 11:00 am – 12:00 pm ET on Thursday, March 18, 2021 via video conference. The first 15 minutes of the Q&A reserved event are open to members of the media. A second Q&A will follow the panel discussion. Register to attend using the following link: https://zoom.us/webinar/register/WN_bpNX8iNWTlWvu3kzYoWH6A
Key issues to be discussed at the conference include:
- What are the latest results from the use of ivermectin in the prevention and treatment of COVID-19 in larger numbers?
- Is ivermectin effective in preventing and treating the variants of COVID-19?
- What is the safety record of ivermectin for COVID-19 prevention and treatment?
- What have we learned from countries and regions using Ivermectin to prevent and treat COVID-19 that will lead to increased use by more governments?
The panel will be modeled by Dr. Mobeen syed, President and Founder DrBeen.com and DrBeen Online Medical Education.
Medical expert panellists:
- Pierre Kory, MPA, MD, President and Chief Medical Officer, FLCCC
- Former Head of Critical Care Service and Medical Director at the Trauma and Life Support Center at the University of Wisconsin
- Eli Schwartz, MD, DTMH, Center for Geographic Medicine and Tropical Diseases, Chaim Sheba Medical Center, Israel
- A center recognized by the Israeli Ministry of Health for tropical diseases and travel.
- Tess lawrie, MBBCh, PhD, Director, The Consultancy Based Medicine Consultancy Ltd., United Kingdom
- Recently completed meta-analysis of ivermectin for the treatment of COVID-19
- Hector carvallo, MD, Professor of Medicine, Mayor of Adolfo Ibanez y Universidad University
- Former Director of Ezeiza Public Hospital, Argentina
- Marc Wathelet, PhD, Molecular and cellular biologist, Coronavirus expert, Belgium
- Specializes in the study of respiratory viruses.
- He has led several research projects into various strains of coronavirus, including SARS-CoV, which caused severe respiratory infection in 2003-2004.
About the COVID-19 Front Line Critical Care Alliance
The FLCCC Alliance was formed in March 2020 by a worldwide group of published emergency care physicians / scholars – with academic support from allied physicians from around the world – to review and develop safety protocols- life for the prevention and treatment of COVID-19 in all stages of the disease. Their MATH + Hospital Treatment Protocol – introduced in March 2020, has saved thousands of critically ill patients with COVID-19. Now, the new FLCCC Prophylaxis I-Mask + and Ivermectin Early Home Patient Treatment Protocol have been released – and it is a potential solution in global pandemic disease.
For more information: https://covid19criticalcare.com/